Furthermore, an in vivo study has shown that PARP1 activation is associated with the pathogeneses of Alzheimer’s disease [95] and Parkinson’s disease [96], indicating that PARP1 deficiency prevents brain dysfunction and cognitive decline. Here, PARP1 is linked to Alzheimer disease.